These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15835500)

  • 1. Not so NICE. A proposal from the National Institute for Clinical Excellence to withdraw treatments for Alzheimer's disease from the NHS has left support groups reeling.
    Heath H
    Nurs Older People; 2005 Apr; 17(2):8. PubMed ID: 15835500
    [No Abstract]   [Full Text] [Related]  

  • 2. Counting costs. Patients will suffer from limits on Alzheimer's drugs.
    Page S
    Nurs Stand; 2005 May 25-31; 19(37):24-5. PubMed ID: 15938410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic results: tacrine].
    Ventura M; Sternon J
    Rev Med Brux; 1997 Dec; 18(6):394-7. PubMed ID: 9481161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institute for Clinical Excellence. Alzheimer's drugs given go-ahead.
    Nurs Times; 2001 Jan 25-31; 97(4):7. PubMed ID: 11954136
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing health economic outcome in Alzheimer's disease clinical trials.
    Jonsson L
    J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationing is essential in tax-funded health systems.
    Lancet; 2006 Oct; 368(9545):1394. PubMed ID: 17055922
    [No Abstract]   [Full Text] [Related]  

  • 7. [Delaying Alzheimer dementia. Patient and family relieved--costs lowered].
    MMW Fortschr Med; 2000 Aug; 142(33-34):56-7. PubMed ID: 10998909
    [No Abstract]   [Full Text] [Related]  

  • 8. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Winblad B; Hill S; Beermann B; Post SG; Wimo A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515
    [No Abstract]   [Full Text] [Related]  

  • 9. Experts disagree over NICE's approach for assessing drugs.
    Hoey R
    Lancet; 2007 Aug; 370(9588):643-4. PubMed ID: 17726791
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.
    Ward A; Caro JJ; Getsios D; Ishak K; O'Brien J; Bullock R;
    Int J Geriatr Psychiatry; 2003 Aug; 18(8):740-7. PubMed ID: 12891643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-effectiveness of galantamine in a german context].
    Happich M; Schweikert B; Mühlbacher A
    Psychiatr Prax; 2005 Apr; 32(3):142-50. PubMed ID: 15818530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost control in Alzheimer therapy. "Second class patient"].
    MMW Fortschr Med; 2002 Dec; 144(50):67. PubMed ID: 14610878
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's disease: clinical features and pharmacologic management.
    Franks AS; Rawls WN
    Am J Manag Care; 1998 Apr; 4(4):595-604; quiz 606-7. PubMed ID: 10179918
    [No Abstract]   [Full Text] [Related]  

  • 14. Alzheimer's disease medication: use and cost projections for Medicare Part D.
    Morden NE; Zerzan JT; Larson EB
    J Am Geriatr Soc; 2007 Apr; 55(4):622-4. PubMed ID: 17397444
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cost of illness in Alzheimer's disease].
    Kiencke P; Rychlik R; Grimm C; Daniel D
    Med Klin (Munich); 2010 May; 105(5):327-33. PubMed ID: 20503006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do we treat people with dementia in Croatia.
    Mimica N; Presecki P
    Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer's disease.
    Iliffe S
    CNS Drugs; 2007; 21(3):177-84. PubMed ID: 17338591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NICE proposes to withdraw Alzheimer's drugs from NHS.
    Kmietowicz Z
    BMJ; 2005 Mar; 330(7490):495. PubMed ID: 15746112
    [No Abstract]   [Full Text] [Related]  

  • 19. UK government guidance on Alzheimer's drugs postponed.
    O'Neill MF
    Drug Discov Today; 2005 Sep; 10(17):1132. PubMed ID: 16182201
    [No Abstract]   [Full Text] [Related]  

  • 20. International price comparisons of Alzheimer's drugs: a way to close the affordability gap.
    Suh GH; Wimo A; Gauthier S; O'Connor D; Ikeda M; Homma A; Dominguez J; Yang BM;
    Int Psychogeriatr; 2009 Dec; 21(6):1116-26. PubMed ID: 19735595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.